Claudine Q. Homolash is an experienced personal injury lawyer, representing injured individuals in catastrophic cases.  She also has successfully resolved many pharmaceutical cases against major drug companies involving drugs in clinical trial and on the market and has been the lead counsel in various whistleblower actions throughout the country.  She is admitted to practice in Pennsylvania, New York and New Jersey.  Ms. Homolash has been recognized by her peers and by legal organizations, including the National Trial Lawyers as a “Top 40 Under 40” attorney in Pennsylvania.  She has been recognized as a Pennsylvania SuperLawyer in 2013, as well as, a Pennsylvania Rising Star in 2010, 2011, and 2012 by the national SuperLawyer organization.  In 2009, Ms. Homolash was named a Pennsylvania “Lawyer on the Fast Track,” an award given to 30 lawyers in the Commonwealth of Pennsylvania under the age of 40 who have demonstrated outstanding promise in the legal profession and have made a significant commitment to advocacy, working selflessly to better the circumstances and lives of those in their communities. 

Ms. Homolash was the lead attorney at her prior firm on the Avandia, Gadolinium Contrast Dye, Vioxx, Bextra, Celebrex, Medtronic Heart Device and Guidant Heart Device litigations.    

Ms. Homolash is an active member of numerous organizations, including:  Editorial Board Member for The Legal Intelligencer; State Delegate for the Pennsylvania Association for Justice; State Delegate and Women’s Law Caucus member for the American Association for Justice; member of the Temple American Inn of Court; member of the Justinian Society; and the MS Society.  Ms. Homolash earned her B.S. degree from Saint Joseph’s University and her J.D. degree from Villanova University School of Law.